Mycobacterium tuberculosis (Mtb) is the causative agent of tuberculosis, an infectious
disease with one of the highest morbidity and mortality rates worldwide. Leveraging its …

In 1999, the World Health Organization (WHO) estimated that one-third of the world's
population had latent tuberculosis infection (LTBI), which was recently updated to one …

The introduction and broad use of new immunosuppressive agents, including biologic
agents and JAK inhibitors, have revolutionised treatment of inflammatory bowel disease …

Tuberculosis (TB) is the leading infectious cause of mortality worldwide, due in part to a
limited understanding of its clinical pathogenic spectrum of infection and disease …

Tuberculosis is a public health problem worldwide, including in the United States—
particularly among immunocompromised patients and other high-risk groups. Tuberculosis …

Identification and treatment of latent tuberculosis infection (LTBI) can substantially reduce
the risk of develo** active disease. However, there is no diagnostic gold standard for LTBI …

Breakthrough findings in the clinical and preclinical development of tuberculosis (TB)
vaccines have galvanized the field and suggest, for the first time since the development of …

Is Mycobacterium tuberculosis infection life long? | The BMJ Skip to main content Intended for
healthcare professionals Access provided by Google Indexer Subscribe My Account My email …

Diagnosis of tuberculosis, and especially the diagnosis of extrapulmonary tuberculosis, still
faces challenges in clinical practice. There are several reasons for this. Methods based on …

In 2005, CDC published guidelines for using the QuantiFERON-TB Gold test (QFT-
G)(Cellestis Limited, Carnegie, Victoria, Australia)(CDC. Guidelines for using the …